Key genetic variants in the GLP1R gene (rs6923761), GIPR gene (rs1800437), and FTO gene (rs9939609) affect receptor sensitivity, hormone signaling, and baseline metabolic rate
Studies show that patients lost an average of 14.9% of their baseline body weight after 68 weeks, or about 35 pounds
The "GLP-3" (retatrutide) appears more effective for weight loss in clinical trials than GLP-1-only medications
Positioned as the final, highest-tier titration milestone, the 15mg KwikPen helps patients confidently maintain peak metabolic performance, systematically cutting down intensive food cravings while maintaining steady energy levels
If you experience persistent blood glucose readings above 15 mmol/L with symptoms or ketones present, seek same-day clinical advice from your GP, urgent care centre, or NHS 111